Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company’s Digital Pathology Business
Healthcare IT Today
DECEMBER 27, 2022
Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A Source: Markets and Markets “Digital Pathology Market, Global Forecast to 2025”; Signify Research “Digital Pathology – World – 2018”.
Let's personalize your content